Pharmaceutical Chemistry Journal, volume 53, issue 4, pages 288-297

Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs

Publication typeJournal Article
Publication date2019-07-09
Quartile SCImago
Q4
Quartile WOS
Q4
Impact factor0.9
ISSN0091150X, 15739031
Drug Discovery
Pharmacology
Abstract
Conjugates for targeted delivery that are based on low-molecular-mass prostate specific membrane antigen (PSMA) inhibitors are widely used and developed because of the deficiencies of existing methods for treating and diagnosing prostate cancer. The major classes of low-molecular-mass PSMA inhibitors, drug classes, and their mechanisms of action are discussed. Therapeutic conjugates for targeted delivery that are based on them are analyzed. Structural features of the linker that affect the biological activity and selectivity are identified.

Citations by journals

1
Mendeleev Communications
Mendeleev Communications, 1, 50%
Mendeleev Communications
1 publication, 50%
Molecules
Molecules, 1, 50%
Molecules
1 publication, 50%
1

Citations by publishers

1
Elsevier
Elsevier, 1, 50%
Elsevier
1 publication, 50%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 1, 50%
Multidisciplinary Digital Publishing Institute (MDPI)
1 publication, 50%
1
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Uspenskaya A. A. et al. Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs // Pharmaceutical Chemistry Journal. 2019. Vol. 53. No. 4. pp. 288-297.
GOST all authors (up to 50) Copy
Uspenskaya A. A., Machulkin A. E., Mazhuga A. G., Beloglazkina E. K. Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs // Pharmaceutical Chemistry Journal. 2019. Vol. 53. No. 4. pp. 288-297.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s11094-019-01994-1
UR - https://doi.org/10.1007%2Fs11094-019-01994-1
TI - Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs
T2 - Pharmaceutical Chemistry Journal
AU - Uspenskaya, A A
AU - Machulkin, A E
AU - Mazhuga, A G
AU - Beloglazkina, E K
PY - 2019
DA - 2019/07/09 00:00:00
PB - Springer Nature
SP - 288-297
IS - 4
VL - 53
SN - 0091-150X
SN - 1573-9031
ER -
BibTex |
Cite this
BibTex Copy
@article{2019_Uspenskaya,
author = {A A Uspenskaya and A E Machulkin and A G Mazhuga and E K Beloglazkina},
title = {Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs},
journal = {Pharmaceutical Chemistry Journal},
year = {2019},
volume = {53},
publisher = {Springer Nature},
month = {jul},
url = {https://doi.org/10.1007%2Fs11094-019-01994-1},
number = {4},
pages = {288--297},
doi = {10.1007/s11094-019-01994-1}
}
MLA
Cite this
MLA Copy
Uspenskaya, A. A., et al. “Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs.” Pharmaceutical Chemistry Journal, vol. 53, no. 4, Jul. 2019, pp. 288-297. https://doi.org/10.1007%2Fs11094-019-01994-1.
Found error?